|
HDHD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.25739435425021E-13 |
| Normal-vs-Stage3 |
2.99760216648792E-15 |
| Normal-vs-Stage4 |
3.89680000000281E-05 |
| Stage1-vs-Stage2 |
9.709800E-01 |
| Stage1-vs-Stage3 |
8.216100E-02 |
| Stage1-vs-Stage4 |
2.820000E-01 |
| Stage2-vs-Stage3 |
1.263770E-01 |
| Stage2-vs-Stage4 |
2.492200E-01 |
| Stage3-vs-Stage4 |
9.716400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.66422431391311E-12 |
| Normal-vs-Asian |
4.70300021149228E-10 |
| Caucasian-vs-AfricanAmerican |
3.704200E-01 |
| Caucasian-vs-Asian |
1.786440E-01 |
| AfricanAmerican-vs-Asian |
1.644010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.79967152291738E-13 |
| Male-vs-Female |
2.636000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.79349868290046E-11 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.62447832963153E-12 |
| Normal-vs-Extreme_Obese |
1.142090E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.275800E-02 |
| Normal_Weight-vs-Obese |
3.290800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.131600E-01 |
| Extreme_Weight-vs-Obese |
3.324400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.976000E-01 |
| Obese-vs-Extreme_Obese |
3.447600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63491442606301E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
5.94519988794673E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.379600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.233780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.595840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.489200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.351800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.303400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.13495887635418E-13 |
| Normal-VS-KIRP CIMP |
1.62458935193399E-12 |
| Normal-VS-Unclassified PRCC |
1.62492241884138E-12 |
| Type1 PRCC-VS-Type2 PRCC |
3.610300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.44509999999254E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
9.719600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.97050000042098E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
9.453800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.246700E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.50990331349021E-14 |
| Normal-vs-N2 |
7.6349000455167E-09 |
| N0-vs-N1 |
2.315400E-01 |
| N0-vs-N2 |
9.378300E-02 |
| N1-vs-N2 |
3.220600E-01 |
|
|
